Thoraxcenter, Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands.
Am J Cardiol. 2011 Dec 1;108(11):1536-41. doi: 10.1016/j.amjcard.2011.07.010. Epub 2011 Sep 8.
Early reperfusion of the infarct-related coronary artery is an important issue in improvement of outcomes after ST-segment elevation myocardial infarction (STEMI). In this study, the clinical significance of total ischemic time on myocardial reperfusion and clinical outcomes was evaluated in patients with STEMI treated with primary percutaneous coronary intervention and thrombus aspiration and additional triple-antiplatelet therapy. Total ischemic time was defined as time from symptom onset to first intracoronary therapy (first balloon inflation or thrombus aspiration). All patients with STEMI treated with primary percutaneous coronary intervention with total ischemic times ≥30 minutes and <24 hours from 2005 to 2008 were selected. Ischemic times were available in 1,383 patients, of whom 18.4% presented with total ischemic times ≤2 hours, 31.2% >2 to 3 hours, 26.8% >3 to 5 hours, and 23.5% >5 hours. Increased ischemic time was associated with age, female gender, hypertension, and diabetes. Patients with total ischemic times <5 hours more often had myocardial blush grade 3 (40% to 45% vs 22%, p <0.001) and complete ST-segment resolution (55% to 60% vs 42%, p = 0.002) than their counterparts with total ischemic times >5 hours. In addition, patients with total ischemic times ≤5 hours had lower 30-day mortality (1.5% vs 4.0%, p = 0.032) than patients with total ischemic times >5 hours. In conclusion, in this contemporary cohort of patients with STEMI treated with primary percutaneous coronary intervention, triple-antiplatelet therapy, and thrombus aspiration, short ischemic time was associated with better myocardial reperfusion and decreased mortality. After a 5-hour period in which outcomes remain relatively stable, myocardial reperfusion becomes suboptimal and mortality increases.
急性 ST 段抬高型心肌梗死(STEMI)患者经直接经皮冠状动脉介入治疗(PCI)和血栓抽吸治疗联合三联抗血小板治疗后,梗死相关动脉早期再灌注是改善预后的关键。本研究旨在评估 STEMI 患者的总缺血时间与心肌再灌注和临床结局的相关性。
入选 2005 年至 2008 年直接 PCI 治疗且总缺血时间≥30 分钟且<24 小时的 STEMI 患者,定义总缺血时间为症状发作至首次冠状动脉治疗(首次球囊扩张或血栓抽吸)的时间。共纳入 1383 例患者,其中 18.4%患者的总缺血时间≤2 小时,31.2%患者的总缺血时间>23 小时,26.8%患者的总缺血时间>35 小时,23.5%患者的总缺血时间>5 小时。与总缺血时间较长的患者相比,总缺血时间较短的患者年龄更大、女性比例更高、高血压和糖尿病更为常见。总缺血时间<5 小时的患者心肌梗死溶栓试验(TIMI)心肌灌注分级 3 级(40%45%比 22%,p<0.001)和完全 ST 段回落(55%60%比 42%,p=0.002)的比例更高。此外,总缺血时间≤5 小时的患者 30 天死亡率(1.5%比 4.0%,p=0.032)低于总缺血时间>5 小时的患者。
综上,在直接 PCI 治疗、三联抗血小板治疗和血栓抽吸治疗的当代 STEMI 患者中,较短的缺血时间与更好的心肌再灌注和更低的死亡率相关。5 小时后,心肌再灌注效果逐渐不佳,死亡率逐渐升高。